Related Experiment Video
Updated: Aug 10, 2026

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
Published on: May 11, 2018
[Mechanical cardiac assistance and artificial heart: historical perspectives]
E Flecher1, T Joudinaud, J-M Grinda
1Service de chirurgie cardiovasculaire, hôpital européen Georges-Pompidou, 20-40, rue Leblanc, 75015 Paris, France. erwan.flecher@wanadoo.fr
Abstract:
The impact of heart failure on patients and economical burden on health insurance resources is increasing. Cardiac transplantation is still the primary treatment for patients who are in end stage heart failure. The development of artificial hearts (total and partial) was implemented by the discrepancy between the scarcity of available donors and the importance of waiting lists for cardiac transplantation. The technical progresses achieved since the first works of Kolff in 1957 now allow these patients to have their circulation restored and go home to wait for their transplantation. The encouraging results of the artificial heart and the miniaturization of these devices allow them to be considered as a possible destination therapy for patients not eligible for cardiac transplantation.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Heart Failure VI: Adjunct Therapies
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure V: Medical Management

